Patrys Receives $3.35m R&D tax incentive refund
Patrys (PAB) subsidiary Nucleus Therapeutics receives a $3.35 million research and development tax incentive refund from the...
Patrys Receives new $100k research grant for metastatic breast cancer
The Victorian government awards Patrys (PAB) a $100,000 Victorian Medical Research Acceleration Fund (VMRAF)...
